Use of garlicin in preparation of hyperlipoidemia treatment medicines
A technology for hyperlipidemia and medicine is applied in the application field of allicin in the preparation of medicine for treating hyperlipidemia, and achieves the effects of smooth stool, clear medicine source and obvious therapeutic effect.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0025] Example 1 Preparation of enteric-coated garlic tablets
[0026] The enteric-coated garlic tablet is prepared by using freeze-dried garlic powder (alliin content ≥ 30mg / g) as the main raw material and adding suitable pharmaceutical excipients, using existing pharmaceutical technology, and preparing it into tablets, and then coating it with enteric-coated film;
[0027] The tablet weight of described enteric-coated garlic tablet is 500mg, and composition weight percent is:
[0028] (1) Freeze-dried garlic powder (alliin content ≥ 30mg) 70%,
[0029] (2) Pharmaceutical excipients (including coating materials) 30%;
[0030] After the enteric-coated garlic tablets are made, the results of high-performance liquid chromatography show that the content of alliin is 10mg~11mg / tablet, and the potential allicin is greater than 5mg / tablet.
Embodiment 2
[0031] Embodiment 2 pharmacodynamic research
[0032] Animal models of hyperlipidemia and normal animals (SD rats, half male and half female, body weight 200±20g, provided by the Experimental Animal Center of Fudan University) were selected to evaluate the lipid-lowering effect of enteric-coated garlic tablets according to conventional test methods.
[0033] The results showed that the enteric-coated garlic tablets high, medium and low dose groups could significantly reduce the serum triglyceride level of normal rats, and the serum triglyceride level of the high dose group and the medium dose group decreased more significantly; Dosage group can significantly reduce the serum cholesterol level in normal rats;
[0034] The enteric-coated garlic tablet high, medium and low dose groups can significantly reduce the triglyceride level and low-density lipoprotein level in the serum of hyperlipidemia model rats, and wherein the lowering of the triglyceride level is more obvious; The ...
Embodiment 3
[0035] Example 3 Clinical Research
[0036] The present invention carries out clinical observation on the patients with fatty liver combined with hyperlipidemia.
[0037] Research objects: The observed cases were all outpatients, a total of 120 cases were randomly divided into treatment group and control group, including 80 cases in the treatment group (54 males and 26 females), with an average age of 45.4 years and an average course of disease of 3.5 years; the control group There were 40 cases (29 males and 11 females), with an average age of 44.9 years and an average disease duration of 3.6 years.
[0038] Efficacy Judgment Standards:
[0039] (1) Clinical symptoms and signs improve or disappear;
[0040] (2) Refer to the "Guiding Principles for Clinical Research": TC decrease ≥ 20%, or TG decrease ≥ 40%, or HDL increase ≥ 20%;
[0041] (3) The B-ultrasound examination basically returned to normal, and the characteristics of fatty liver decreased;
[0042] (4) ALT retur...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com